Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Dosage Forms &Delivery Systems for Antitumor Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
American Samoa Affiliated Collaborative Performance Agreement for Tobacco Control
Health Management Strategies for Recovery
The cell biology of Toll-like receptor 9: a mechanism to prevent autoimmunity
Hormonal Control of Chondrocyte Cartilage Synthesis
Indirect Bridge Health Monitoring Using Moving Vehicles
Recently added grants:
Neurobehavioral mechanisms of parent-child extinction learning in adolescent PTSD
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites
Functions, mechanisms, and therapeutic potential of fetal hemoglobin inducers
Use of forward Genetic approaches to identify Babesia receptors
Nanoscience of Self 2.0: blocking CD47 recognition by phagocytes in blood & solid tumor clearance
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
261200700011C-2-0-1
Application #
7585918
Study Section
Project Start
2007-08-01
Project End
2012-07-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$279,246
Indirect Cost
Related projects
NIH 2008
N02 CA
Development of Dosage Forms &Delivery Systems for Antitumor Agents
/ University of Kansas Lawrence
$269,024
NIH 2007
N01 CA
Development of Dosage Forms &Delivery Systems for Antitumor Agents
/
$279,246
Comments
Be the first to comment on this grant